Sign In
Buy BIO
$301.90
-2.46 (-0.81%)
At Close: Jul 20, 2026
Laxxon Medical to Attend BIO-Europe and Jefferies Healthcare Conference World Premier Life Science Partnering Events
07:00am, Monday, 27'th Oct 2025
NEW YORK--(BUSINESS WIRE)--Laxxon announces attendance at BIO-Europe and Jefferies Healthcare Conference.
BKYI: BIO-key International and IT2Trust Partner to Strengthen IAM and Biometric Security Across the Nordic Region of Denmark, Sweden, Norway and Finland.
Securian Asset Management Inc. Sells 100 Shares of Bio-Rad Laboratories, Inc. $BIO
04:50am, Sunday, 26'th Oct 2025
Securian Asset Management Inc. trimmed its position in Bio-Rad Laboratories, Inc. (NYSE: BIO) by 6.7% in the second quarter, according to its most recent filing with the SEC. The fund owned 1,389 shar
Bio-Rad Laboratories, Inc. $BIO Shares Sold by DekaBank Deutsche Girozentrale
04:12am, Sunday, 26'th Oct 2025
DekaBank Deutsche Girozentrale lessened its stake in shares of Bio-Rad Laboratories, Inc. (NYSE: BIO) by 1.0% in the second quarter, according to its most recent filing with the SEC. The fund owned 12
Compelling Value In Small-Cap Equities And Select Cyclicals
11:45pm, Thursday, 23'rd Oct 2025
Supplier of residential thermal, comfort and security solutions, Resideo Technologies, Inc. (REZI) was the top contributor in the quarter. Shares of gold mining company, Barrick Mining Corporation (B)
7 Stocks Taking The Next Step To Be On Offense
07:30pm, Thursday, 23'rd Oct 2025
Bio-Rad Laboratories was a positive contributor after the company reported steadier earnings than the market expected. PVH also remains our largest share repurchaser for the year after buying a teens
Bio-Rad Laboratories (BIO) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
11:08am, Wednesday, 22'nd Oct 2025
Bio-Rad (BIO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Bio-Rad Laboratories (BIO) to Release Earnings on Wednesday
03:50am, Wednesday, 22'nd Oct 2025
Bio-Rad Laboratories (NYSE: BIO - Get Free Report) is expected to announce its Q3 2025 results after the market closes on Wednesday, October 29th. Analysts expect the company to announce earnings of $
BIO-key Introduces EcoID III USB Fingerprint Scanner Delivering FBI FAP 20 Certification, Liveness Detection and Encrypted Device-to-Host Communication.
Analysts Set Bio-Rad Laboratories, Inc. (NYSE:BIO) PT at $333.50
01:14am, Monday, 20'th Oct 2025
Bio-Rad Laboratories, Inc. (NYSE: BIO - Get Free Report) has earned a consensus rating of "Hold" from the six ratings firms that are covering the stock, Marketbeat Ratings reports. One investment anal
Bio-Rad to Report Third Quarter 2025 Financial Results on Wednesday, October 29, 2025
05:30pm, Thursday, 16'th Oct 2025
HERCULES, Calif.--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, will report its financial results for t
BIO-key Showcases Next-Gen Identity & Biometric Authentication Solutions at Premier Tech and Cybersecurity Events: GITEX 2025 (Dubai) & 19ENISE (Spain).
Hoth Therapeutics CEO Robb Knie to Present at BIO-Europe in Vienna, Austria November 3-5, 2025
07:57am, Tuesday, 07'th Oct 2025
Presentation to highlight advancements in Hoth's clinical pipeline, includingHT-001 for cancer-therapy-induced rash and HT-KIT, a novel oncology programtargeting KIT-driven tumors NEW YORK , Oct. 7, 2
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of 8
Biorad Medisys announces its entry into the US market with the launch of its new subsidiary Medtimo Inc.
05:19pm, Thursday, 04'th Sep 2025
PUNE, India, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Biorad Medisys, an Indian medical device manufacturer with a global footprint, has announced its entry into the US market with the launch of its subsidi
